Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin response in active epilepsy

G J Schapel1, R G Beran, D L Kennaway

  • 1Comprehensive Epilepsy Service, Queen Elizabeth Hospital, Woodville, Australia.

Epilepsia
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical errors and mistakes: civil or criminal liability?

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Lamotrigine - Interactions matter!

Epilepsy & behavior : E&B·2020
Same author

Legal imperatives in treating severe stroke.

International journal of stroke : official journal of the International Stroke Society·2016
Same author

Justification for conducting neurological clinical trials as part of patient care within private practice.

International journal of clinical practice·2016
Same author

Generic substitution in contravention of doctor's prescriptions.

Internal medicine journal·2015
Same author

Author reply: To PMID 25442756.

Internal medicine journal·2015
Same journal

Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

Epilepsia·2026
Same journal

Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

Epilepsia·2026
Same journal

Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

Epilepsia·2026
Same journal

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same journal

Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

Epilepsia·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
See all related articles

Patients with active epilepsy exhibit higher 24-hour urinary excretion of 6-sulfatoxymelatonin (aMT.6S), a melatonin metabolite. This increase is primarily driven by elevated nocturnal melatonin production, suggesting altered circadian patterns in epilepsy.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Chronobiology

Background:

  • Melatonin is a key hormone regulating circadian rhythms.
  • Epilepsy is a neurological disorder characterized by recurrent seizures.
  • Disruptions in circadian rhythms have been implicated in various neurological conditions.

Purpose of the Study:

  • To investigate melatonin production in patients with untreated active epilepsy.
  • To compare urinary 6-sulfatoxymelatonin (aMT.6S) excretion patterns between epilepsy patients and healthy controls.
  • To determine if epilepsy affects the circadian rhythm of melatonin production.

Main Methods:

  • Collected 24-hour urine samples from 30 untreated active epilepsy patients and 19 healthy subjects.
  • Measured urinary 6-sulfatoxymelatonin (aMT.6S) excretion in three consecutive 8-hour intervals.

Related Experiment Videos

  • Utilized analysis of variance (ANOVA) to compare excretion rates between groups.

    • Main Results:

    • Patients with active epilepsy showed significantly higher total 24-hour aMT.6S excretion (77.3 nmol) compared to healthy subjects (49.1 nmol).
    • The difference in total output was primarily due to significantly greater nocturnal (2200-0600 h) aMT.6S excretion in epilepsy patients.
    • ANOVA revealed a significant difference in total output driven by nocturnal excretion (p = 0.018).

    Conclusions:

    • Untreated active epilepsy is associated with increased melatonin production.
    • Melatonin production in epilepsy patients exhibits a circadian pattern with a phase difference compared to normal subjects.
    • These findings suggest a potential link between altered melatonin circadian rhythms and epilepsy.